# SR One Portfolio Map 2026: 59 Startups by Sector > SR One's portfolio mapped: 59 startups it has backed, in 3 sectors from Biotech, Pharma and Healthtech on. $8.3B raised between them; logos, funding and rounds. Source: https://millionrounds.com/portfolio-maps/sr-one-portfolio-map (Millionrounds; every figure on the page links to its filing or article) ## Biotech 45 - [*TP* Turning Point Therapeutics](https://millionrounds.com/company/turning-point-therapeutics) - [Dren Bio](https://millionrounds.com/company/dren-bio) - [Windward Bio](https://millionrounds.com/company/windward-bio) - [Alumis](https://millionrounds.com/company/alumis) - [Morphic Therapeutic](https://millionrounds.com/company/morphic-therapeutic) - [CORXEL Pharmaceuticals](https://millionrounds.com/company/corxel-pharmaceuticals) - [Arcellx](https://millionrounds.com/company/arcellx) - [Odyssey Therapeutics](https://millionrounds.com/company/odyssey-therapeutics) - [AirNexis Therapeutics](https://millionrounds.com/company/airnexis-therapeutics) - [Spero Therapeutics](https://millionrounds.com/company/spero-therapeutics) - [Decibel Therapeutics](https://millionrounds.com/company/decibel-therapeutics) - [HotSpot Therapeutics](https://millionrounds.com/company/hotspot-therapeutics) - [MiroBio](https://millionrounds.com/company/mirobio) - [True North Therapeutics](https://millionrounds.com/company/true-north-therapeutics) - [*TT* TP Therapeutics](https://millionrounds.com/company/tp-therapeutics) - [MISSION Therapeutics](https://millionrounds.com/company/mission-therapeutics) - [Pulmocide](https://millionrounds.com/company/pulmocide) - [Bicycle Therapeutics](https://millionrounds.com/company/bicycle-therapeutics) - [FORE Biotherapeutics](https://millionrounds.com/company/fore-biotherapeutics) - [Palleon Pharmaceuticals](https://millionrounds.com/company/palleon-pharmaceuticals) - [Addition Therapeutics](https://millionrounds.com/company/addition-therapeutics) - [Effector Therapeutics](https://millionrounds.com/company/effector-therapeutics) - [NuPathe](https://millionrounds.com/company/nupathe) - [Principia BioPharma](https://millionrounds.com/company/principia-biopharma) +21 more ## Pharma 9 - [CRISPR THERAPEUTICS](https://millionrounds.com/company/crispr-therapeutics) - [Zenas BioPharma](https://millionrounds.com/company/zenas-biopharma) - [*CT* Crystalys Therapeutics](https://millionrounds.com/company/crystalys-therapeutics) - [ORIC Pharmaceuticals](https://millionrounds.com/company/oric-pharmaceuticals) - [Draig Therapeutics](https://millionrounds.com/company/draig-therapeutics) - [ARS Pharmaceuticals](https://millionrounds.com/company/ars-pharmaceuticals) - [Renalys Pharma](https://millionrounds.com/company/renalys-pharma) - [*GT* Gryphon Therapeutics](https://millionrounds.com/company/gryphon-therapeutics) - [*O* OctoPlus](https://millionrounds.com/company/octoplus) ## Healthtech 5 - [VeraDermics](https://millionrounds.com/company/veradermics) - [Poplar Therapeutics](https://millionrounds.com/company/poplar-therapeutics) - [*R2* River 2 Renal](https://millionrounds.com/company/river-2-renal) - [*PB* POINT Biomedical](https://millionrounds.com/company/point-biomedical) - [*RV* River Vision Development](https://millionrounds.com/company/river-vision-development) ## Segment by segment ### Biotech 45 startups · $5.7B raised - [*TP* **Turning Point Therapeutics**](https://millionrounds.com/company/turning-point-therapeutics) Turning Point Therapeutics is a pharmaceutical company that discovers and develops precision medicines for cancer and other diseases. - $460M - [**Dren Bio**](https://millionrounds.com/company/dren-bio) Dren Bio focuses on protein engineering technologies for depletion of cells, protein aggregates, and other disease-causing agents. United States $375M - [**Windward Bio**](https://millionrounds.com/company/windward-bio) Windward Bio is a clinical-stage biotechnology company with deep discovery, development, and commercialization expertise committed Switzerland $365M - [**Alumis**](https://millionrounds.com/company/alumis) Alumis is a precision medicine company focused on the discovery, development and treatment of autoimmune disorders. United States $345M - [**Morphic Therapeutic**](https://millionrounds.com/company/morphic-therapeutic) Morphic Therapeutic is a biotechnology company that develops oral integrin therapies to treat serious chronic diseases. United States $328M - [**CORXEL Pharmaceuticals**](https://millionrounds.com/company/corxel-pharmaceuticals) CORXEL Pharmaceuticals is a clinical-stage biopharmaceutical company founded in 2019, previously known as JiXing Pharmaceuticals. United States $287M - [**Arcellx**](https://millionrounds.com/company/arcellx) Arcellx is a clinical-stage biotechnology company focused on developing innovative immunotherapies for cancer and other incurable diseases. United States $285M - [**Odyssey Therapeutics**](https://millionrounds.com/company/odyssey-therapeutics) Odyssey Therapeutics creates precision immunomodulators and oncology medicines for patients with cancer and inflammatory diseases. United States $238M ### Pharma 9 startups · $1.9B raised - [**CRISPR THERAPEUTICS**](https://millionrounds.com/company/crispr-therapeutics) CRISPR Therapeutics is focused on the development of transformative medicines using its proprietary CRISPR/Cas9 gene-editing platform. United States $550M - [**Zenas BioPharma**](https://millionrounds.com/company/zenas-biopharma) Zenas BioPharma is a biopharmaceutical company that focuses on developing immune-based therapies for patients. United States $420M - [*CT* **Crystalys Therapeutics**](https://millionrounds.com/company/crystalys-therapeutics) United States $335M - [**ORIC Pharmaceuticals**](https://millionrounds.com/company/oric-pharmaceuticals) ORIC Pharmaceuticals is a biopharmaceutical company that develops treatments that target the causes of therapeutic resistance. United States $248M - [**Draig Therapeutics**](https://millionrounds.com/company/draig-therapeutics) Draig Therapeutics is a clinical-stage biotechnology company based in Cardiff, Wales, focused on developing innovative neuropsychi United Kingdom $216M - [**ARS Pharmaceuticals**](https://millionrounds.com/company/ars-pharmaceuticals) ARS Pharmaceuticals is a stealth pharmaceutical company that specializes in developing anti allergy drugs. United States $100M - [**Renalys Pharma**](https://millionrounds.com/company/renalys-pharma) Renalys Pharma is a private, late-stage clinical biopharmaceutical business in Japan focused on the discovery of novel medications. Japan $39M - [*GT* **Gryphon Therapeutics**](https://millionrounds.com/company/gryphon-therapeutics) Gryphon Therapeutics is a biopharmaceutical company focused on the development of performance-enhanced protein therapeutics. - $26M ### Healthtech 5 startups · $682M raised - [**VeraDermics**](https://millionrounds.com/company/veradermics) VeraDermics is a dermatology company that creates novel drug delivery mechanisms for a pain-free cure for skin conditions such as warts. United States $534M - [**Poplar Therapeutics**](https://millionrounds.com/company/poplar-therapeutics) Poplar Therapeutics anti-IgE therapy treats atopic diseases such as food allergy, allergic asthma, and atopic dermatitis. United States $50M - [*R2* **River 2 Renal**](https://millionrounds.com/company/river-2-renal) River 2 Renal is a developer of novel therapies intended to cure orphan diseases. - $40M - [*PB* **POINT Biomedical**](https://millionrounds.com/company/point-biomedical) POINT Biomedical, develops technologies for imaging and drug deliveries. United States $29M - [*RV* **River Vision Development**](https://millionrounds.com/company/river-vision-development) River Vision Development develops a protein therapy for the treatment of Graves’ orbitopathy. United States $28M **How this map is made.** Every startup here has raised money in a round we track that names SR One as an investor, the first in 2002. Each sits under its main sector, read from its rounds, and each sector shows its best-funded first; sectors with fewer than three companies are left off. Rebuilt nightly; updated 15 November 2026. ## More portfolio maps [All portfolios](https://millionrounds.com/portfolio-maps) [Corporate investor · United States **Google Ventures** 350 startups · 12 sectors · $99B](https://millionrounds.com/portfolio-maps/gv-portfolio-map)[Corporate investor · United States **Coinbase Ventures** 305 startups · 12 sectors · $16B](https://millionrounds.com/portfolio-maps/coinbase-portfolio-map)[Corporate investor · United States **Intel Capital** 295 startups · 12 sectors · $23B](https://millionrounds.com/portfolio-maps/intel-capital-portfolio-map)[Corporate investor · United States **Salesforce Ventures** 290 startups · 12 sectors · $200B](https://millionrounds.com/portfolio-maps/salesforce-ventures-portfolio-map)[Corporate investor · United States **Endeavor Catalyst** 181 startups · 12 sectors · $22B](https://millionrounds.com/portfolio-maps/endeavor-catalyst-portfolio-map)[Corporate investor · United States **Samsung Next** 170 startups · 12 sectors · $15B](https://millionrounds.com/portfolio-maps/samsung-next-portfolio-map) ## Raising from investors like SR One? Find the investors who back startups like yours, with their cheques, rounds and partners, in the app with filters, lists and exports. [Find investors](https://millionrounds.com/login?join=1&next=/app/investors)[Market maps](https://millionrounds.com/market-maps)